EGF and breast cancer: Finally, our data suggested that PN1 was a positive-feedback regulator of EGF signaling in breast cancer cells, which could block HtrA1 and prevent EGF cleavage, and EGF could then stimulate the metastatic spread of mammary tumors through induction of PN-1.